Latest News about CYTK

Recent news which mentions CYTK

< Previous 1 2 3 4 5 6 Next >

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More

May 22, 2022

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation

May 17, 2022

10 Biggest Price Target Changes For Monday

May 16, 2022

Cytokinetics: Q1 Earnings Insights

May 04, 2022

70 Biggest Movers From Friday

May 02, 2022

48 Stocks Moving In Friday's Mid-Day Session

April 29, 2022

Cytokinetics's Omecamtiv Mecarbil Shows No Effect On Exercise Capacity In Heart Failure Patients

April 04, 2022

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

March 27, 2022

Cytokinetics: Q4 Earnings Insights

February 24, 2022

Cytokinetics Posts Cohort 3 Data From Aficamten Trial In Heart Disease Patients

February 01, 2022

56 Biggest Movers From Friday

January 10, 2022

33 Stocks Moving In Friday's Mid-Day Session

January 07, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021

December 22, 2021

What 5 Analyst Ratings Have To Say About Cytokinetics

December 10, 2021

Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021

December 10, 2021

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré

December 07, 2021

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More

December 06, 2021

A bargain you can’t ignore: Small-cap stocks are trading at their second-lowest discount in 20 years

November 04, 2021

Cytokinetics, Incorporated (CYTK) Q3 2021 Earnings Call Transcript

November 04, 2021

Where Cytokinetics Stands With Analysts

October 08, 2021

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

October 08, 2021

Expert Ratings For Cytokinetics

October 07, 2021

Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021

October 07, 2021

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal

October 06, 2021

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

October 05, 2021

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

October 01, 2021

Cramer Weighs In On Cytokinetics, LegalZoom And Matterport

September 29, 2021

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive

September 28, 2021

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

September 17, 2021

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

August 31, 2021

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.